The NF-κB pathway involved in the progression of liver fibrosis by activating and transcribing genes such as BCL2 and IL-1, which allow aHSCs to survive and maintain qHSC activation [34–36]. This evidence concerns the gene BCL2 and Hepatic fibrosis.